CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Ahmad Doroudian, hereby certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
the Quarterly Report on Form 10-Q of Neurokine
Pharmaceuticals Inc. for the period ended April 30, 2011 (the "Report")
fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
the information contained in the Report fairly presents,
in all material respects, the financial condition and results of
operations of Neurokine Pharmaceuticals Inc..
Dated: June 14, 2011
||/s/ Ahmad Doroudian
||Ahmad Doroudian |
||President, Chief Executive Officer and Director
||(Principal Executive Officer) |
||Neurokine Pharmaceuticals Inc.
A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Neurokine
Pharmaceuticals Inc. and will be retained by Neurokine Pharmaceuticals Inc. and
furnished to the Securities and Exchange Commission or its staff upon